Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
and even that somehow we had in entire study 3:1 over 65 years old in the drug , and study was 2:1
Impatient people don’t get paid.
and in contrary to lenzilumab with mortality with subgroups
We SS for Length of Hospitalization for entire trial
we reduced over 80% progression from moderate to severe
If FDA will approve the same protocol for leronlimab , as they did for Remdesivir and Lenzilumab.
We too will " PICK " at the results during our study , we will change primary endpoint to length of hospitalization , we be SS and have EUA now.
Short attack triggering stop losses. Now they'll slowly buy back.
Evidence about the importance of macrophages in severe Covid keeps piling up confirming lenzilumab's mechanism of action. Below citation posted by Jerry on ST.
https://scitechdaily.com/new-cell-atlas-of-covid-lungs-reveals-why-sars-cov-2-is-different-and-deadly/
“In COVID-19, we see expansion and uncontrolled activation of macrophages, including alveolar macrophages and monocyte-derived macrophages,” Izar says. “They are completely out of balance and allow inflammation to ramp up unchecked. This results in a vicious cycle where more immune cells come in causing even more inflammation, which ultimately damages the lung tissue.”
One inflammatory cytokine in particular, IL-1ß, is produced at a high rate by these macrophages.
“Unlike other cytokines such as IL-6, which appears to be universally prevalent in various pneumonias, IL-1ß production in macrophages is more pronounced in COVID-19 compared to other viral or bacterial lung infections,” Izar says. “That’s important because drugs exist that tamp down the effects of IL-1ß.”
In my opinion there will be Leronlimab into UK soon!!!
why a man with no biotech experience decides to suddenly buy an abandoned drug
He openly said he had invested in CYDY. What is he lying about then.
This weekend's homework for Shorts. Lenzilumab is a GM-CSF inhibitor.
CAR-T
https://www.nature.com/articles/s41408-021-00459-7
https://www.nature.com/articles/s41421-021-00255-4
https://www.targetedonc.com/view/lenzilumab-plus-axi-cel-achieves-responses-in-100-of-patients-with-dlbcl-with-limited-toxicity-in-small-study
https://www.healio.com/news/hematology-oncology/20210422/lenzilumab-before-cart-induces-high-response-rates-without-severe-toxicities
HGEN Summary
https://www.reddit.com/r/Humanigen/comments/n1a4q4/another_awesome_dd/
Covid
https://www.bbc.com/news/health-56352128
https://immunology.sciencemag.org/content/6/57/eabg9873
https://directorsblog.nih.gov/2021/04/13/mapping-severe-covid-19-in-the-lungs-at-single-cell-resolution/
https://www.nature.com/articles/s41586-021-03569-1
https://www.pharmaceutical-technology.com/news/humanigen-lenzilumab-improves-survival/
Why are hearing about the 28 CSPs in the Philippines but nothing at all about the eINDS and OLEs in the United States? Are they still accepting patients in the United States? Or are they "officially" accepting more patients while in reality not doing it?
half of the shareholders in Lenzilumab have no interest in Lenzilumab , and love to talk , and research only Leronlimab .,
In a way I understand , it is a much better drug
He freely disclosed his investment
What are you accusing him of ? Is this your opinion or do you have proof of foul play
CytoDyn should consider renaming the company as CriscoDyn because they are so greasy. Always highlight what you are good at doing.
This is 100% wrong , I believe that Dr Nicolas even introduced CYDY to Chiral..and Dr Nicolas said , he has no financial benefit from leronlimab , not in any way.
Randy became a believer and bought stock and is supporting the team .
Can you provide a link for this?
The S-3 form is from August, 2019. In other words, before Covid. So Dr Randy did arduous research on Covid and came to the conclusion that the stock that he was already invested in had the drug that was the game changer. How convenient.
Every time Dr Randy talks about leronlimab's costs or his financial relationship with leronlimab, he stumbles over his words and never will directly answer the question given to him. It is now obvious why he gets nervous.
every long here is in the same boat
If they gave him something for his very hard work I don’t know
But as a compensation he should have more ..
He said once that he was so impressed with Leronlimab that he started to invested some in this company
This is 100% wrong , I believe that Dr Nicolas even introduced CYDY to Chiral..and Dr Nicolas said , he has no financial benefit from leronlimab , not in any way.
Is this (Randy) Nicolas MD without the glasses?
Don- Where can that be confirmed?
Richard is Randy's real name.
If true, I'm fixing to go wide with this one.
Richard is Randy's real name.
And by hiring Chiral they can do some really greasy things not possible in the US. Do SEC filings specify how much CytoDyn paid Chiral?
Ummm Don "That" is not calling "leronlimab" by name
You have to click on "show replies" under Tomorrow's Future's response.
Where did Estrada call leronlimab by name as the wonder drug?
One million COVID cases in 3 days in India. It has gotten out of control there with very low oxygen supply and overwhelmed hospitals.
— JV Ejercito (@jvejercito) April 26, 2021
Praying for India too.
"son of former president of Philippine" was referencing remdesivir, not leronlimab.
And yes Lenzilumab suppress so much GM-CSF that it may produce immunosuppression
They need to say nothing ,they received leronlimab and they are a live.
And we know that , not from them but from a doctors ...
They are ALL HUMANS , and their lives are saved by Leronlimab
WRONG...they have Leronlimab and successful trial just submitted to the FDA that will create a market share of 20 billion dollars. Actually that should be reworded, it's not a market share as they will own the entire market
I am sure they do believe in Lenzilumab , Dr Fauci told them to do.
Entire world I believe see already a difference with Leronlimab...
this is why they ask only for Leronlimab ..the .."Wonder Drug " as son of former president of Philippine like to cal Leronlimab
Why FDA is not approving the same protocol for all the studies
Another thing we know NOBODY is asking for lenz, nobody!